子宫内膜样子宫内膜癌淋巴播散的预测:单机构队列中三种风险分层模型的比较
本研究纳入1052例I-III期子宫内膜样子宫内膜癌患者,比较Mayo、Helsinki和Milwaukee三种风险分层模型预测淋巴播散的表现。三种模型的曲线下面积分别为0.781、0.830和0.829,假阴性和假阳性率相似,淋巴结清扫率以Milwaukee模型最低(48.8%)。生存分析提示模型变量可独立于肿瘤分期预测患者结局。
要点
- Mayo、Helsinki和Milwaukee模型预测淋巴播散的AUC分别为0.781、0.830和0.829,准确性相似。
- 淋巴结清扫率由高到低依次为Mayo模型71.5%、Helsinki模型62.4%、Milwaukee模型48.8%。
- I期患者中,符合任一模型低风险标准者疾病特异性生存更好;II-III期患者中仅Milwaukee模型差异显著。
核心结论
- 三种模型预测子宫内膜癌淋巴播散的准确性相似,Milwaukee模型的淋巴结清扫率最低;生存分析提示模型所含变量可独立于肿瘤分期预测患者结局。
研究设计与样本
- 单机构队列研究,纳入1052例I-III期子宫内膜样子宫内膜癌患者,中位随访55个月(范围1-108个月)。
- 采用受试者工作特征曲线下面积比较检验比较AUC,卡方检验和Fisher精确检验比较分类变量,Kaplan-Meier法和多变量Cox回归模型进行生存分析。
主要发现
- 预测淋巴播散的AUC:Mayo模型0.781,Helsinki模型0.830(对比Mayo模型P=0.285),Milwaukee模型0.829(对比Mayo模型P=0.292)。
- 各模型假阴性和假阳性率相似。
- 淋巴结清扫率由高到低依次为Mayo模型71.5%、Helsinki模型62.4%、Milwaukee模型48.8%。
- I期患者中,符合任一模型低风险标准者疾病特异性生存更好;II-III期患者中,仅Milwaukee模型的生存差异显著。
- 淋巴播散和风险模型定义的高危肿瘤特征均为生存的独立预测因素。
关键数值与推荐
- Mayo模型预测淋巴播散的AUC为0.781。
- Helsinki模型预测淋巴播散的AUC为0.830(对比Mayo模型P=0.285)。
- Milwaukee模型预测淋巴播散的AUC为0.829(对比Mayo模型P=0.292)。
- 淋巴结清扫率:Mayo模型71.5%,Helsinki模型62.4%,Milwaukee模型48.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the performance characteristics of 3 risk-stratification models, referred to as Mayo, Helsinki and Milwaukee models, in predicting lymphatic dissemination in endometrial cancer. METHODS: A total of 1052 patients with stage I-III endometrioid endometrial cancer were included in the study. The areas under curve were compared with the receiver operating characteristic curve area comparison test. Chi-square and Fisher exact test were used for comparing categorical variables. The Kaplan-Meier method and multivariable Cox regression models were used for survival analyses. The median follow-up time was 55months (range 1-108). RESULTS: Areas under curve were 0.781, 0.830 and 0.829 for the Mayo, Helsinki (P=0.285 vs. Mayo) and Milwaukee (P=0.292 vs. Mayo) models, respectively, in predicting lymphatic dissemination. The rates of false negatives and false positives were similar for all models. The lymphadenectomy rate decreased in the order of Mayo model (71.5%)>Helsinki model (62.4%)>Milwaukee model (48.8%). In patients with stage I cancer, disease specific survival was better for those who satisfied low-risk criteria according to any of the models. In patients with stage II-III cancer, this difference in survival was significant only for the Milwaukee model. Both lymphatic dissemination and high-risk tumor features as per the risk models were independent predictors of survival. CONCLUSIONS: The studied models had a similar accuracy in predicting lymphatic dissemination in endometrial cancer. Lymphadenectomy rate was lowest for the Milwaukee model. Survival analyses suggest that variables included in the models predict patient outcome independently of tumor stage.
引用
- Tuomi T, Pasanen A, Leminen A, et al. Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort. Gynecol Oncol. 2017. PMID: 28069268. doi:10.1016/j.ygyno.2017.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。